|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-3-8
|
|
pubmed:abstractText |
Adequate early mycophenolic acid (MPA) exposure is an important determinant for effective rejection prophylaxis. This pharmacokinetic study investigated whether an intensified dosing regimen of enteric-coated mycophenolate sodium (EC-MPS) could achieve higher mycophenolic acid (MPA) exposure early after transplantation versus a standard dosing regimen.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-10440399,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-10702523,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-11856782,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-1244564,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-14508385,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-14974944,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-14974945,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-15196064,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-15367210,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-15575908,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-15740555,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-15795646,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-16570022,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-16628123,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-17109728,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-17201457,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-17699403,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-17868068,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-18498916,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-18580456,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-18946341,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-19333146,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-7645033,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-7752752,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-8623181,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-9646007,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20150450-9871432
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1555-905X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
503-11
|
|
pubmed:dateRevised |
2011-7-25
|
|
pubmed:meshHeading |
pubmed-meshheading:20150450-Administration, Oral,
pubmed-meshheading:20150450-Adult,
pubmed-meshheading:20150450-Antibodies, Monoclonal,
pubmed-meshheading:20150450-Area Under Curve,
pubmed-meshheading:20150450-Chi-Square Distribution,
pubmed-meshheading:20150450-Cyclosporine,
pubmed-meshheading:20150450-Drug Therapy, Combination,
pubmed-meshheading:20150450-Feasibility Studies,
pubmed-meshheading:20150450-Female,
pubmed-meshheading:20150450-Germany,
pubmed-meshheading:20150450-Graft Rejection,
pubmed-meshheading:20150450-Graft Survival,
pubmed-meshheading:20150450-Humans,
pubmed-meshheading:20150450-IMP Dehydrogenase,
pubmed-meshheading:20150450-Immunosuppressive Agents,
pubmed-meshheading:20150450-Kidney Transplantation,
pubmed-meshheading:20150450-Male,
pubmed-meshheading:20150450-Middle Aged,
pubmed-meshheading:20150450-Mycophenolic Acid,
pubmed-meshheading:20150450-Pilot Projects,
pubmed-meshheading:20150450-Prospective Studies,
pubmed-meshheading:20150450-Recombinant Fusion Proteins,
pubmed-meshheading:20150450-Tablets, Enteric-Coated,
pubmed-meshheading:20150450-Time Factors,
pubmed-meshheading:20150450-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Pharmacokinetics and pharmacodynamics of intensified versus standard dosing of mycophenolate sodium in renal transplant patients.
|
|
pubmed:affiliation |
Department of Nephrology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. petra.glander@charite.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
